APLM
Apollomics·NASDAQ
--
--(--)
--
--(--)
0.87 / 10
Underperform
Evaluation yields 0.9/10, reflecting subpar financial health. Key positives: Interest coverage ratio (EBIT / Interest expense) (%), although drawbacks are visible in Days sales outstanding and Operating revenue (YoY growth rate %). This configuration appears challenging.
Analysis Checks(1/4)
Total operating revenue (YoY growth rate %)
Value294.17
Score0/3
Weight42.13%
1M Return-6.11%
Value294.17
Score0/3
Weight42.13%
1M Return-6.11%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Days sales outstanding
Value76.24
Score1/3
Weight12.52%
1M Return-1.57%
Value76.24
Score1/3
Weight12.52%
1M Return-1.57%
Operating revenue (YoY growth rate %)
Value392.33
Score0/3
Weight36.26%
1M Return-5.06%
Value392.33
Score0/3
Weight36.26%
1M Return-5.06%
Total operating revenue (YoY growth rate %)
Value294.17
Score0/3
Weight42.13%
1M Return-6.11%
Value294.17
Score0/3
Weight42.13%
1M Return-6.11%
Days sales outstanding
Value76.24
Score1/3
Weight12.52%
1M Return-1.57%
Value76.24
Score1/3
Weight12.52%
1M Return-1.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value392.33
Score0/3
Weight36.26%
1M Return-5.06%
Value392.33
Score0/3
Weight36.26%
1M Return-5.06%
Is APLM fundamentally strong?
- APLM scores 0.87/10 on fundamentals and holds a Premium valuation at present. Backed by its -5380.26% ROE, 0.00% net margin, -1.32 P/E ratio, -9.39 P/B ratio, and -83.47% earnings growth, these metrics solidify its Underperform investment rating.
